In Canada, one man in seven risks developing prostate cancer. It is the most frequently diagnosed cancer in men and its incidence has increased by 30 percent since 1988. While most commonly diagnosed
In Canada, one man in seven risks developing prostate cancer. It is the most frequently diagnosed cancer in men and its incidence has increased by 30 percent since 1988. While most commonly diagnosed after age 70, prostate cancer can also occur in men in their forties and fifties.
Like other forms of cancer, this disease affects not only the patient but also his family. At the time of diagnosis, there are many questions that need to be answered. This book provides a simple, concise, practical guide to help patients understand prostate cancer. Now in its third edition, it has, over the years, become an indispensable reference work. It is an outstanding source of information on the prevention and causes of prostate cancer, its early diagnosis and the treatment options available, including their side effects and complications.
View Biographical note
Dr. Fred Saad is a professor of surgery at the University of Montreal. He is currently chief of Urology and Director of Urologic Oncology at the University of Montreal Hospital Centre (Centre Hospitalier de l'Université de Montréal, CHUM). He also heads the Molecular Prostate Cancer Research Lab at the Montreal Cancer Institute and is Director of Oncology Research at the CHUM research centre. Since 2004, he has held the University of Montreal Chair in Prostate Cancer Research. In 2005, he received the Leadership Award in Medicine from the University of Montreal Hospital Centre.
Dr. Saad is a past president of the Quebec Urological Association and is currently president of the National Cancer Institute of Canada G-U Group, the Canadian Urologic Oncology Group and GU Global. He is a member of ten editorial boards and serves as a reviewer for more than 30 urology and oncology journals. He has published over 300 scientific articles and book chapters and has collaborated on over 800 scientific abstracts presented at scientific meetings around the world. He is co-editor of several books, including the first two editions of Understanding Prostate Cancer, which sold over 120,000 copies.
His main research interests include molecular prognostic markers in prostate cancer and new treatments for advanced prostate cancer. He is currently coordinating more than 40 clinical and basic research projects in urologic oncology. Nationally and internationally, he has been an invited speaker/professor over 300 times, due to his involvement in research and medical education.
Dr. Michael McCormack is a urologist, the assistant head of urology at the University of Montreal Hospital Centre (Centre Hospitalier de l'Université de Montréal, CHUM) and associate clinical professor in the Department of Surgery, Faculty of Medicine, University of Montreal.
After completing his studies in medullary neurophysiology at McGill University, Dr. McCormack studied medicine at the University of Montreal. He received his doctorate in 1983 and finished his urology training in 1988. He chose to begin his career in private practice in Saint-Jean-sur-Rlchelieu, where he was also head of urology and head of the surgery unit at the local hospital. In 2000, he joined the urology team at the University of Montreal Hospital Centre.
Dr. McCormack served as chair of the Quebec college of physicians' urology examination committee and vice-chair of the Examination Board in urology at the Royal College of Physicians and Surgeons of Canada. A past president of the Quebec Urological Association, he is currently responsible for the website of that organization as well as that of the surgery department of the University of Montreal. He has chaired the IT Committee of the Canadian Urological Association and is now co-editor of a quarterly journal put out by the University of Montreal surgery department.
Dr. McCormack has contributed several chapters to medical books and is the author of two books on medical topics for the general public: <